{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T06:43:43Z","timestamp":1793083423137,"version":"4.5.0"},"reference-count":24,"publisher":"BMJ","issue":"10","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["J Clin Pathol"],"accepted":{"date-parts":[[2018,6,16]]},"published-print":{"date-parts":[[2018,10]]},"abstract":"<jats:p>The<jats:italic>p16<\/jats:italic>gene belongs to<jats:italic>INK4<\/jats:italic>family of genes and is made up of four members: p16<jats:italic><jats:sup>INK4A<\/jats:sup><\/jats:italic>, p15<jats:italic><jats:sup>INK4B<\/jats:sup><\/jats:italic>, p18<jats:italic><jats:sup>INK4C<\/jats:sup><\/jats:italic>and p19<jats:italic><jats:sup>INK4D<\/jats:sup><\/jats:italic>, all of which share biological properties, namely, inhibition of cell growth and tumour suppression. After<jats:italic>p53<\/jats:italic>,<jats:italic>p16<\/jats:italic>is the second most common tumour suppressor gene. It has been regarded as the familial melanoma gene. Immunohistochemistry for p16 has a well-defined role in distinct pathological scenarios. It is used to distinguish desmoplastic melanoma from reactive fibrous proliferation, with former showing strong nuclear positivity. In other types of melanoma, p16 protein expression is lost. Spitz nevi show retention of nuclear staining for p16. Benign mesothelial proliferations tend to retain nuclear p16 immunoreactivity, while malignant mesotheliomas lose expression. However,<jats:italic>p16<\/jats:italic>fluorescent in-situ hybridisation analysis is recommended in the workup of malignant mesothelioma. Another common application of p16 immunohistochemistry is as an indicator for human papillomavirus (HPV) infection and p16 protein is overexpressed in HPV-associated tumours. In this context, p16 immunopositivity should be strong, diffuse, nuclear or nuclear and cytoplasmic in location. Another use for p16 is demonstration of p16 immunopositivity in well-differentiated and dedifferentiated liposarcoma.<\/jats:p>","DOI":"10.1136\/jclinpath-2018-205216","type":"journal-article","created":{"date-parts":[[2018,8,3]],"date-time":"2018-08-03T16:14:30Z","timestamp":1533312870000},"page":"853-858","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":124,"title":["<i>p16<\/i>"],"prefix":"10.1136","volume":"71","author":[{"given":"Stefano","family":"Serra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2124-515X","authenticated-orcid":false,"given":"Runjan","family":"Chetty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2018,8,3]]},"reference":[{"key":"2024053001333631000_71.10.853.1","doi-asserted-by":"publisher","DOI":"10.1006\/excr.1997.3824"},{"key":"2024053001333631000_71.10.853.2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6600862"},{"key":"2024053001333631000_71.10.853.3","doi-asserted-by":"publisher","DOI":"10.1038\/371257a0"},{"key":"2024053001333631000_71.10.853.4","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1202737"},{"key":"2024053001333631000_71.10.853.5","doi-asserted-by":"publisher","DOI":"10.1021\/bi200642e"},{"key":"2024053001333631000_71.10.853.6","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1210507"},{"key":"2024053001333631000_71.10.853.7","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1998.16.3.1197"},{"key":"2024053001333631000_71.10.853.8","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.humpath.2016.07.029","article-title":"Loss of p16 expression and copy number changes of CDKN2A in a spectrum of spitzoid melanocytic lesions","volume":"58","author":"Harms","year":"2016","journal-title":"Hum Pathol"},{"key":"2024053001333631000_71.10.853.9","doi-asserted-by":"crossref","DOI":"10.1186\/s13000-015-0431-9","article-title":"A p16-Ki-67-HMB45 immunohistochemistry scoring system as an ancillary diagnostic tool in the diagnosis of melanoma","volume":"10","author":"Uguen","year":"2015","journal-title":"Diagn Pathol"},{"key":"2024053001333631000_71.10.853.10","doi-asserted-by":"publisher","DOI":"10.1136\/jclinpath-2017-204975"},{"key":"2024053001333631000_71.10.853.11","doi-asserted-by":"publisher","DOI":"10.1097\/PAI.0b013e3181719223"},{"key":"2024053001333631000_71.10.853.12","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0b013e3182417330"},{"key":"2024053001333631000_71.10.853.13","doi-asserted-by":"publisher","DOI":"10.1177\/1066896915595465"},{"key":"2024053001333631000_71.10.853.14","doi-asserted-by":"publisher","DOI":"10.1093\/carcin\/23.7.1127"},{"key":"2024053001333631000_71.10.853.15","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.2008.45"},{"key":"2024053001333631000_71.10.853.16","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1097\/PAS.0000000000000529","article-title":"Utility of BAP1 Immunohistochemistry and p16 (CDKN2A) FISH in the Diagnosis of Malignant Mesothelioma in Effusion Cytology Specimens","volume":"40","author":"Hwang","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"2024053001333631000_71.10.853.17","doi-asserted-by":"publisher","DOI":"10.1097\/01.pap.0000201828.92719.f3"},{"key":"2024053001333631000_71.10.853.18","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9440(10)65689-1"},{"key":"2024053001333631000_71.10.853.19","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.humpath.2015.12.021","article-title":"Practical issues in the application of p16 immunohistochemistry in diagnostic pathology","volume":"51","author":"Mahajan","year":"2016","journal-title":"Hum Pathol"},{"key":"2024053001333631000_71.10.853.20","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2559.2002.01465.x"},{"key":"2024053001333631000_71.10.853.21","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0b013e318253a2d1"},{"key":"2024053001333631000_71.10.853.22","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0b013e3181e84652"},{"key":"2024053001333631000_71.10.853.23","doi-asserted-by":"crossref","first-page":"559","DOI":"10.5858\/arpa.2017-0286-CP","article-title":"Human papillomavirus testing in head and neck carcinomas: guideline from the college of American pathologists","volume":"142","author":"Lewis","year":"2018","journal-title":"Arch Pathol Lab Med"},{"key":"2024053001333631000_71.10.853.24","doi-asserted-by":"publisher","DOI":"10.1016\/S1097-2765(00)80042-8"}],"container-title":["Journal of Clinical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/jclinpath-2018-205216","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,30]],"date-time":"2024-05-30T15:54:27Z","timestamp":1717084467000},"score":1,"resource":{"primary":{"URL":"https:\/\/jcp.bmj.com\/lookup\/doi\/10.1136\/jclinpath-2018-205216"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,3]]},"references-count":24,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2018,9,19]]},"published-print":{"date-parts":[[2018,10]]}},"alternative-id":["10.1136\/jclinpath-2018-205216"],"URL":"https:\/\/doi.org\/10.1136\/jclinpath-2018-205216","relation":{},"ISSN":["0021-9746","1472-4146"],"issn-type":[{"value":"0021-9746","type":"print"},{"value":"1472-4146","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,3]]}}}